These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17046775)

  • 41. A strategy for the generation of biomimetic ligands for affinity chromatography. Combinatorial synthesis and biological evaluation of an IgG binding ligand.
    Teng SF; Sproule K; Hussain A; Lowe CR
    J Mol Recognit; 1999; 12(1):67-75. PubMed ID: 10398398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Molecular and genetic analysis of influenza A viruses isolated in Russia, based on the neuraminidase and M2 protein gene sequence].
    Rotanov M; Grebennikova TV; Burtseva EI; Shevchenko ES
    Mol Gen Mikrobiol Virusol; 2008; (2):27-32. PubMed ID: 18488446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amino-terminal anchored surface display in insect cells and budded baculovirus using the amino-terminal end of neuraminidase.
    Borg J; Nevsten P; Wallenberg R; Stenstrom M; Cardell S; Falkenberg C; Holm C
    J Biotechnol; 2004 Oct; 114(1-2):21-30. PubMed ID: 15464595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Expression of the hemagglutinin and neuramidinase gene of influenza A virus H1N1 in Pichia methanolica].
    Zhang Y; Yu Z; Xin L; Chen Y; Tang Q; Chen Y; Chen Q; Shu Y
    Sheng Wu Gong Cheng Xue Bao; 2010 Aug; 26(8):1068-73. PubMed ID: 21090110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1.
    Duwe S; Schweiger B
    J Virol Methods; 2008 Nov; 153(2):134-41. PubMed ID: 18725246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies.
    Lo CY; Wu Z; Misplon JA; Price GE; Pappas C; Kong WP; Tumpey TM; Epstein SL
    Vaccine; 2008 Apr; 26(17):2062-72. PubMed ID: 18378366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.
    Liu AL; Wang HD; Lee SM; Wang YT; Du GH
    Bioorg Med Chem; 2008 Aug; 16(15):7141-7. PubMed ID: 18640042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.
    Jadhao SJ; Achenbach J; Swayne DE; Donis R; Cox N; Matsuoka Y
    Vaccine; 2008 Mar; 26(14):1742-50. PubMed ID: 18336962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influenza A virus matrix protein 1 interacts with hTFIIIC102-s, a short isoform of the polypeptide 3 subunit of human general transcription factor IIIC.
    Huang S; Chen J; Wang H; Sun B; Wang H; Zhang Z; Zhang X; Chen Z
    Arch Virol; 2009; 154(7):1101-10. PubMed ID: 19521658
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors.
    Escuret V; Frobert E; Bouscambert-Duchamp M; Sabatier M; Grog I; Valette M; Lina B; Morfin F; Ferraris O
    J Clin Virol; 2008 Jan; 41(1):25-8. PubMed ID: 18055253
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma.
    Safdar A; Rodriguez MA; Fayad LE; Rodriguez GH; Pro B; Wang M; Romaguera JE; Goy AH; Hagemeister FB; McLaughlin P; Bodey GP; Kwak LW; Raad II; Couch RB
    J Infect Dis; 2006 Nov; 194(10):1394-7. PubMed ID: 17054068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Influenza season 2007/'08 in the Netherlands: antigenic variation, oseltamivir resistance and vaccine composition for the 2008/'09 season].
    Rimmelzwaan GF; de Jong JC; Donker GA; Meijer A; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2008 Sep; 152(39):2138-44. PubMed ID: 18856032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.
    Huleatt JW; Nakaar V; Desai P; Huang Y; Hewitt D; Jacobs A; Tang J; McDonald W; Song L; Evans RK; Umlauf S; Tussey L; Powell TJ
    Vaccine; 2008 Jan; 26(2):201-14. PubMed ID: 18063235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Graphical representation and numerical characterization of H5N1 avian flu neuraminidase gene sequence.
    Nandy A; Basak SC; Gute BD
    J Chem Inf Model; 2007; 47(3):945-51. PubMed ID: 17417832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation.
    Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Kashiwagi S
    J Infect; 2009 Sep; 59(3):207-12. PubMed ID: 19619898
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.
    Van Reeth K; Braeckmans D; Cox E; Van Borm S; van den Berg T; Goddeeris B; De Vleeschauwer A
    Vaccine; 2009 Oct; 27(45):6330-9. PubMed ID: 19840669
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Affinity purification of mouse monoclonal IgE using a protein A mimetic ligand (TG19318) immobilized on solid supports.
    Palombo G; Rossi M; Cassani G; Fassina G
    J Mol Recognit; 1998; 11(1-6):247-9. PubMed ID: 10076849
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A benzoic acid inhibitor induces a novel conformational change in the active site of Influenza B virus neuraminidase.
    Lommer BS; Ali SM; Bajpai SN; Brouillette WJ; Air GM; Luo M
    Acta Crystallogr D Biol Crystallogr; 2004 Jun; 60(Pt 6):1017-23. PubMed ID: 15159560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and screening of a rationally designed combinatorial library of affinity ligands mimicking protein L from Peptostreptococcus magnus.
    Roque AC; Taipa MA; Lowe CR
    J Mol Recognit; 2005; 18(3):213-24. PubMed ID: 15688433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.